ENTITY

Kite Pharma Inc (KITE US)

4
Analysis
Health Care • United States
Kite Pharma, Inc. develops and manufacturers pharmaceuticals. The Company offers and designs cancer immunotherapeutic products and therapy designed to restoring the patient's immune system to recognize and eradicate tumors.
more
•28 Sep 2018 18:05

Japan CAR-T Therapy Landscape

Japan CAR-T therapy - Competitive landscapeJapan pharma catching-up with global players… but a large gap remains Novartis AG (NOVN SE)’ Kymriah...

•27 May 2021 01:08

CARsgen Therapeutics IPO Initiation: Choosing Therapies À La CAR-T

CARsgen is pre-marketing an HKEx IPO to raise proceeds of $400-500m. The promising prospects for the lead product, credible management and a good...

Logo
489 Views
Share
bullish•Binex Co Ltd
•12 Apr 2018 17:28

Binex - Paving the Way for Next-Gen Biotech Breakthrough

We met with Mr. HJ Lee, CEO & President of Binex, followed by a quick site tour in Incheon, Korea, and learned that the company has recently...

Logo
480 Views
Share
bullish•Kite Pharma Inc
•10 Dec 2016 13:48

Kite Pharma: 'Flying Higher' in Red-Hot Cancer Immune-Oncology Space.

With the current pullback in its stock price, we are taking this opportunity to initiate a long position in Kite Pharma Inc (KITE US) , another...

No more insights
x